Mrinal M Patnaik, MBBS

  • 4507 Citations
  • 35 Scopus h-Index
20042019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Mrinal M Patnaik is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 18 Similar Profiles
Leukemia, Myelomonocytic, Chronic Medicine & Life Sciences
Myelodysplastic Syndromes Medicine & Life Sciences
Mutation Medicine & Life Sciences
Survival Medicine & Life Sciences
Acute Myeloid Leukemia Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Primary Myelofibrosis Medicine & Life Sciences
Karyotype Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2004 2019

2 Citations (Scopus)

3023 Mayo Clinic Patients With Myeloproliferative Neoplasms: Risk-Stratified Comparison of Survival and Outcomes Data Among Disease Subgroups

Szuber, N., Mudireddy, M., Nicolosi, M., Penna, D., Vallapureddy, R. R., Lasho, T. L., Finke, C., Begna, K., Elliott, M. A., Hook, C. C., Wolanskyj, A. P., Patnaik, M. M., Hanson, C. A., Ketterling, R. P., Sirhan, S., Pardanani, A. D., Gangat, N., Busque, L. & Tefferi, A., Jan 1 2019, In : Mayo Clinic proceedings.

Research output: Contribution to journalArticle

Polycythemia Vera
Essential Thrombocythemia
Primary Myelofibrosis
Survival
Neoplasms
1 Citation (Scopus)

A prospective evaluation of vitamin B1 (thiamine) level in myeloproliferative neoplasms: clinical correlations and impact of JAK2 inhibitor therapy

Gangat, N., Phelps, A., Lasho, T. L., Finke, C. M., Vallapureddy, R., Hanson, C. A., Ketterling, R. P., Patnaik, M. M., Pardanani, A. D. & Tefferi, A., Feb 1 2019, In : Blood Cancer Journal. 9, 2, 11.

Research output: Contribution to journalLetter

Thiamine
Neoplasms
Therapeutics

Association between anemia and hematological indices with mortality among cardiac intensive care unit patients

Rayes, H. A., Vallabhajosyula, S., Barsness, G. W., Anavekar, N. S., Go, R. S., Patnaik, M. S., Kashani, K. B. & Jentzer, J. C., Jan 1 2019, (Accepted/In press) In : Clinical Research in Cardiology.

Research output: Contribution to journalArticle

Erythrocyte Indices
Intensive Care Units
Anemia
Mortality
Hemoglobins
2 Citations (Scopus)
Open Access
Immune System Diseases
Immunity
B-Lymphocytes
Lymphocytes
T-Lymphocytes
5 Citations (Scopus)

Aurora kinase A inhibition provides clinical benefit, normalizes megakaryocytes, and reduces bone marrow fibrosis in patients with myelofibrosis: A phase I trial

Gangat, N., Marinaccio, C., Swords, R., Watts, J. M., Gurbuxani, S., Rademaker, A., Fought, A. J., Frankfurt, O., Altman, J. K., Wen, Q. J., Farnoud, N., Famulare, C. A., Patel, A., Tapia, R., Vallapureddy, R. R., Barath, S., Graf, A., Handlogten, A., Zblewski, D., Patnaik, M. M. & 14 others, Al-Kali, A., Dinh, Y. T., Prahl, K. E., Patel, S., Nobrega, J. C., Tejera, D., Thomassen, A., Gao, J., Ji, P., Rampal, R. K., Giles, F. J., Tefferi, A., Stein, B. & Crispino, J. D., Aug 15 2019, In : Clinical Cancer Research. 25, 16, p. 4898-4906 9 p.

Research output: Contribution to journalArticle

Aurora Kinase A
Primary Myelofibrosis
Megakaryocytes
Fibrosis
Splenomegaly